Clinical Trials
14 trialsNCT05797246 2026-05-22
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
NCT05453006 2025-07-10
Isbaar
University of Minnesota
Phase NA Completed
NCT05388773 2025-06-19
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
University of Pittsburgh
Phase 2 Recruiting
NCT01901562 2023-11-09
Feasibility and Therapeutic Efficacy of Ductoscopic Papilloma Extraction in Patients With Pathologic Nipple Discharge
Montefiore Medical Center
Phase NA Terminated
NCT01234480 2023-05-16
Intended Use Study of the BD SurePath Plusâ„¢ Pap
Becton, Dickinson and Company
Terminated
NCT05625308 2022-12-22
Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions
Lo.Li.Pharma s.r.l
Phase NA Completed
NCT00591305 2017-05-18
New Therapy of Laryngeal Papilloma In Children
Boston University
Phase NA Terminated
NCT01175499 2014-08-19
TNFE-NBI
University of California, San Francisco
Phase NA Withdrawn
NCT01058317 2013-11-21
Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis
Massachusetts Eye and Ear Infirmary
Phase 2/3 Withdrawn
NCT01827423 2013-04-09
Squamous Cell Carcinoma Antigen Analysis at the University Hospital Ostrava
University Hospital Ostrava
Phase NA Completed
NCT00592319 2012-08-31
Celebrex (Celecoxib) Treatment of Laryngeal Papilloma
Boston University
Phase 2 Terminated
NCT00454181 2011-09-16
Treatment of Oral Warts in HIV+ Patients
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Phase 2 Completed
NCT00001126 2010-08-27
Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00038714 2007-06-27
A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis
Nventa Biopharmaceuticals Corporation
Phase 2 Completed